At week 52, results showed that 65% of patients achieved mycologic cure. The Food and Drug Administration (FDA) has expanded the approval of Jublia® (efinaconazole; Bausch Health) topical solution to ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback